|
|
||||||||
1From the Departments of Cellular Biology and Anatomy, 2Biochemistry and Molecular Biology, and 3Ophthalmology, Medical College of Georgia, Augusta, Georgia.
PURPOSE. Sigma receptors (
Rs) are nonopioid, nonphencyclidine binding sites with robust neuroprotective properties. Type 1
R1 (
R1) is expressed in brain oligodendrocytes, but its expression and binding capacity have not been analyzed in retinal glial cells. This study examined the expression, subcellular localization, binding activity, and regulation of
R1 in retinal Müller cells.
METHODS. Primary mouse Müller cells (MCs) were analyzed by RT-PCR, immunoblotting, and immunocytochemistry for the expression of
R1, and data were compared with those of the rat Müller cell line (rMC-1) and the rat ganglion cell line (RGC-5). Confocal microscopy was used to determine the subcellular
R1 location in primary mouse MCs. Membranes prepared from these cells were used for binding assays with [3H]-pentazocine (PTZ). The kinetics of binding, the ability of various
R1 ligands to compete with
R1 binding, and the effects of donated nitric oxide (NO) and reactive oxygen species (ROS) on binding were examined.
RESULTS.
R1 is expressed in primary mouse MCs and is localized to the nuclear and endoplasmic reticulum membranes. Binding assays showed that in primary mouse MCs, rMC-1, and RGC-5, the binding of PTZ was saturable. [3H]-PTZ bound with high affinity in RGC-5 and rMC-1 cells, and the binding was similarly robust in primary mouse MCs. Competition studies showed marked inhibition of [3H]-PTZ binding in the presence of
R1-specific ligands. Incubation of cells with NO and ROS donors markedly increased
R1 binding activity.
CONCLUSIONS. MCs express
R1 and demonstrate robust
R1 binding activity, which is inhibited by
R1 ligands and is stimulated during oxidative stress. The potential of Müller cells to bind
R1 ligands may prove beneficial in retinal degenerative diseases such as diabetic retinopathy.
This article has been cited by other articles:
![]() |
S. B. Smith, J. Duplantier, Y. Dun, B. Mysona, P. Roon, P. M. Martin, and V. Ganapathy In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4154 - 4161. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Umapathy, J. P. Gnana-Prakasam, P. M. Martin, B. Mysona, Y. Dun, S. B. Smith, V. Ganapathy, and P. D. Prasad Cloning and Functional Characterization of the Proton-Coupled Electrogenic Folate Transporter and Analysis of Its Expression in Retinal Cell Types Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5299 - 5305. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dun, M. Thangaraju, P. Prasad, V. Ganapathy, and S. B. Smith Prevention of Excitotoxicity in Primary Retinal Ganglion Cells by (+)-Pentazocine, a Sigma Receptor-1 Specific Ligand Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4785 - 4794. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |